Medication info
Simroks EF Tablet

Simroks EF Tablet

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Hansoh Pharmaceutical Co., Ltd.
Appearance
A white to off-white, biconvex, rectangular tablet
Packaging
30 tablets ((10 tablets/PTP)x3)
Approval status
Active

MFDS item code 201601084 · Approved 2016.02.26 · Insurance code 621802810

Summary

Main use
Improvement of primary and homozygous familial hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients taking this medicine must follow a standard cholesterol-lowering diet before and during treatment. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. This medicine is administered once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg once daily. The usual recommended initial dose is 10/20mg once daily. For patients who require less reduction in LDL cholesterol, treatment may be initiated at 10/10mg once daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Because of an increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering therapies (e.g., LDL apheresis) or when other lipid-lowering therapies are not available. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, subsection Patients with Abnormal Liver Function, under Precautions for Use). Administration to patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. When administering this medicine at a higher dose to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See 6. Interactions under Precautions for Use) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Ingredients

Manufacturer
Hansoh Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary and homozygous familial hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
  • diabetes
  • hypothyroidism
  • obstructive liver disease
  • chronic renal failure
View approved original text

This medicine helps lower elevated total cholesterol, LDL cholesterol, ApoB protein, and triglycerides, and increase HDL cholesterol in patients with primary hypercholesterolemia, especially in heterozygous familial and non-familial mixed hyperlipidemia. It is also used as an adjunctive treatment for homozygous familial hypercholesterolemia patients when other treatments are not effective, and to reduce the risk of atherosclerotic vascular disease. This drug is administered in conjunction with an appropriate dietary regimen and is generally given when other non-drug treatments are insufficient. Before treatment, secondary causes such as diabetes mellitus and hypothyroidism must be identified and treated if necessary, and the treatment effect should be monitored through regular lipid tests. Early lipid testing and appropriate treatment are also recommended in cases of acute coronary events. This drug is effectively used to improve hypercholesterolemia.

How to take

Adult dose

Patients taking this medicine must follow a standard cholesterol-lowering diet before and during treatment. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. This medicine is administered once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg once daily. The usual recommended initial dose is 10/20mg once daily. For patients who require less reduction in LDL cholesterol, treatment may be initiated at 10/10mg once daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Because of an increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering therapies (e.g., LDL apheresis) or when other lipid-lowering therapies are not available. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, subsection Patients with Abnormal Liver Function, under Precautions for Use). Administration to patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. When administering this medicine at a higher dose to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See 6. Interactions under Precautions for Use) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Precautions

This drug may cause muscle-related side effects such as myopathy or rhabdomyolysis, so if you experience muscle pain or weakness while taking it, you should inform your doctor immediately. Patients with allergies to this drug's components or those with impaired liver function, as well as women who are pregnant or breastfeeding, should not take this medication. In particular, those with liver disease or patients with abnormally high liver enzyme levels in blood tests should not be administered this drug, and liver function tests should be performed regularly during treatment. This drug may interact with certain medications, for example, potent CYP3A4 inhibitors, fibrates, some antibiotics, and antifungal agents can increase the risk of myopathy, so you must inform your physician or pharmacist about any medications you are taking. Special caution is required for the elderly, women, patients with hypothyroidism, and those with impaired kidney function, as the risk of muscle side effects is higher in these groups. Women planning to become pregnant should consult their doctor before taking this drug, and should immediately discontinue use if pregnancy is confirmed. Breastfeeding women should stop breastfeeding when taking this drug, and safety and efficacy in children and adolescents have not been fully established, thus caution is needed. If unexplained muscle pain, weakness, or changes in urine color occur while taking this drug, you should promptly consult healthcare professionals. In case of overdose, since there is no specific antidote, appropriate treatment should be received based on symptoms, and when starting or stopping other medications while taking this drug, it must be done according to medical instructions.

Side effects

  • headache
  • diarrhea
  • influenza
  • upper respiratory tract infection
  • myalgia
  • limb pain
  • fatigue
  • abdominal pain
  • viral infection
  • pharyngitis
Show 80 more
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • creatine phosphokinase elevation
  • myopathy
  • rhabdomyolysis
  • liver aminotransferase elevation
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • sensory disturbances
  • depression
  • cholelithiasis
  • cholecystitis
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reaction with systemic symptoms
  • erythema multiforme
  • liver damage
  • weakness
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • pancreatitis
  • hepatitis
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • erectile dysfunction
  • ocular muscle paralysis
  • anemia
  • aminotransferase elevation
  • ALP elevation
  • gamma-GT elevation
  • bilirubin elevation
  • thyroid dysfunction
  • serum creatine kinase elevation
  • abnormal liver function tests
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture from entering. In addition, it is best to store the medication at room temperature between 1°C and 30°C, avoiding areas that are too hot or too cold.

Appearance and packaging

Appearance

A white to off-white, biconvex, rectangular tablet

Package unit

30 tablets ((10 tablets/PTP)x3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.